SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors aggressively bid up the stock amid an AI-driven memory chip shortage, with community sentiment heavily focused on potential valuation reratings and record-breaking earnings growth. While retail traders express extreme optimism over supply bottlenecks and Wall Street price target hikes, some community voices remain cautious about bubble risks and volatility surrounding the semiconductor supercycle.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust is seeing heightened activity as community members debate whether the asset is entering a fresh breakout phase fueled by industrial demand for chip production and potential supply chain constraints. Traders are closely tracking volatility in the silver-to-gold ratio and futures markets, with active discussions focused on whether the current momentum represents a sustainable bull run or a continuation of historical cycles of sharp, volatility-driven price swings.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing heightened volatility and increased trading volume as the market reacts to early-stage research into an mRNA-based Hantavirus vaccine following a recent cruise ship outbreak. While some retail investors are treating the stock as a pandemic-era play reminiscent of 2020, others are closely monitoring technical indicators and biotech sector rotations, with the community actively debating whether the headlines represent a sustainable catalyst or temporary sentiment-driven hype.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing intense volatility as investors weigh the potential of its strategic partnership with Nvidia against concerns over immediate share dilution from a major convertible notes offering. The community remains sharply divided between long-term bulls betting on the company's AI infrastructure buildout and skeptics wary of persistent capital raises and the stock's recent rapid appreciation.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after reporting a positive final pre-BLA meeting with the FDA, which solidified the development path for sonelokimab in hidradenitis suppurativa. The community is actively discussing the stock's long-term potential, with bullish sentiment focusing on the upcoming Phase 3 data readouts and best-in-class label expectations, while some participants remain cautious due to recent range-bound price action and the risks inherent in clinical-stage biotech.

Xiao-I Corp. is a holding company, which engages in Internet technology development through its subsidiaries. It focuses on business solutions and services in artificial intelligence, covering natural language processing, voice and image recognition, machine learning, and affective computing. The company was founded in 2001 and is headquartered in Shanghai, China.

Xiao-I Corp - ADR

XIAO-I Corporation

XIAO-I Corporation is trending as investors weigh the impact of a forthcoming 1-for-20 reverse stock split against ongoing speculative hopes for a significant legal settlement with Apple. While some community members anticipate a potential short squeeze due to the reduced float and high short interest, others are warning of historical patterns of dilution often associated with small-cap ADR restructurings.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is rallying after a strong earnings beat, with investors buoyed by revenue growth, raised guidance, and signs of success in its AI platform adoption. While the community is actively debating whether the stock is undervalued and primed for a squeeze, many are highlighting the company's solid balance sheet and cash flow as key pillars for its recovery.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing intense retail and momentum interest, driven by its unique positioning in the memory sector and recent defense contract news. Community discourse is heavily focused on the stock's potential as a 'picks-and-shovels' play for the burgeoning Edge AI and robotics markets, with many participants pointing to similarities between this move and previous rallies in larger semiconductor names.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is seeing a massive surge as investors aggressively rotate into the stock, fueled by a combination of bullish analyst upgrades, a major new data center hyperscaler partnership, and high-profile speculation regarding AI device integration. The community is actively debating whether this vertical move represents a sustainable rerating of the company's valuation as it pivots toward AI infrastructure, or if the stock is becoming a sentiment-driven meme trade.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

Mullen is trending as the community rallies around a low-market-cap token, using high-beta speculative narratives and coordination tactics to drive sentiment. Traders are actively comparing it to past corporate history while debating the potential for rapid gains through aggressive social momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alnylam Pharmaceuticals (ALNY) Tops Q1 Earnings and Revenue Estimates

Alnylam (ALNY) delivered earnings and revenue surprises of +39.00% and +2.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Upstream Bio (UPB) to Release Quarterly Earnings on Tuesday

Upstream Bio (NASDAQ:UPB) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...

Upstream Bio, Inc. (NASDAQ:UPB) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Upstream Bio, Inc. (NASDAQ:UPB - Get Free Report) has been given an average rating of "Moderate Buy" by the five analysts that are covering the company, MarketBeat.com reports. One research analyst...

Upstream Bio, Inc. (NASDAQ:UPB) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Upstream Bio, Inc. (NASDAQ:UPB - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five ratings firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, two h...

Upstream Bio (NASDAQ:UPB) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen lowered shares of Upstream Bio from a "hold" rating to a "sell" rating in a research note on Saturday...

Upstream Bio (NASDAQ:UPB) Downgraded by Evercore to In-Line

Evercore downgraded shares of Upstream Bio from an "outperform" rating to an "in-line" rating and set a $15.00 target price on the stock. in a research note on Friday...

Upstream Bio Lead Drug Pivotal Trial Plan Follows Strong Phase 2 Data

Upstream Bio outlines Phase 3 plans for verekitug as asthma and CRSwNP data support dosing strategy; shares rise on update.read more...

Upstream Bio (NASDAQ:UPB) Posts Earnings Results, Misses Estimates By $0.06 EPS

Upstream Bio (NASDAQ:UPB - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.79) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.73) by ($0.06). The company had revenue of $0.67 million for the quarter, compared to analyst...

Upstream Bio (NASDAQ:UPB) Trading Up 11.2% - What's Next?

Upstream Bio (NASDAQ:UPB) Stock Price Up 11.2% - Here's Why...

Upstream Bio (NASDAQ:UPB) Trading 14.4% Higher - Should You Buy?

Upstream Bio (NASDAQ:UPB) Stock Price Up 14.4% - What's Next...

Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA.

UPB
Upstream Bio Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest UPB News

UPBUpstream Bio Inc.